231 related articles for article (PubMed ID: 30264681)
41. Initial Leuprolide Acetate Release from Poly(d,l-lactide-
Li Z; Mu H; Larsen SW; Jensen H; Østergaard J
Mol Pharm; 2020 Dec; 17(12):4522-4532. PubMed ID: 33164519
[TBL] [Abstract][Full Text] [Related]
42. Accelerated in vitro release testing method for a long-acting peptide-PLGA formulation.
Goel M; Leung D; Famili A; Chang D; Nayak P; Al-Sayah M
Eur J Pharm Biopharm; 2021 Aug; 165():185-192. PubMed ID: 33992753
[TBL] [Abstract][Full Text] [Related]
43. Design of novel injectable in-situ forming scaffolds for non-surgical treatment of periapical lesions: In-vitro and in-vivo evaluation.
Shamma RN; Elkasabgy NA; Mahmoud AA; Gawdat SI; Kataia MM; Abdel Hamid MA
Int J Pharm; 2017 Apr; 521(1-2):306-317. PubMed ID: 28235624
[TBL] [Abstract][Full Text] [Related]
44. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
[TBL] [Abstract][Full Text] [Related]
45. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
Kranz H; Bodmeier R
Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
[TBL] [Abstract][Full Text] [Related]
46. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
Cho KY; Lee S; Park JK
Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
[TBL] [Abstract][Full Text] [Related]
47. Formulation and evaluation of floating tablet of H2-receptor antagonist.
Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
[TBL] [Abstract][Full Text] [Related]
48. Development and pharmacokinetic evaluation of alginate-pectin polymeric rafts forming tablets using box behnken design.
Abbas G; Hanif M
Drug Dev Ind Pharm; 2018 Dec; 44(12):2026-2037. PubMed ID: 30084289
[TBL] [Abstract][Full Text] [Related]
49. Application of hydroxyapatite nanoparticles in development of an enhanced formulation for delivering sustained release of triamcinolone acetonide.
Koocheki S; Madaeni SS; Niroomandi P
Int J Nanomedicine; 2011; 6():825-33. PubMed ID: 21589650
[TBL] [Abstract][Full Text] [Related]
50. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
Song X; Song SK; Zhao P; Wei LM; Jiao HS
Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
[TBL] [Abstract][Full Text] [Related]
51. Biodegradable injectable implant systems for long term drug delivery using poly (lactic-co-glycolic) acid copolymers.
Chandrashekar G; Udupa N
J Pharm Pharmacol; 1996 Jul; 48(7):669-74. PubMed ID: 8866326
[TBL] [Abstract][Full Text] [Related]
52. Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation.
Shan-Bin G; Yue T; Ling-Yan J
Drug Dev Ind Pharm; 2015 Apr; 41(4):573-82. PubMed ID: 24502270
[TBL] [Abstract][Full Text] [Related]
53. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
54. Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers.
Hashmat D; Shoaib MH; Ali FR; Siddiqui F
PLoS One; 2020; 15(2):e0228908. PubMed ID: 32107483
[TBL] [Abstract][Full Text] [Related]
55. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
Vora L; V G S; Vavia P
Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
[TBL] [Abstract][Full Text] [Related]
56. Long lasting in-situ forming implant loaded with raloxifene HCl: An injectable delivery system for treatment of bone injuries.
Elkasabgy NA; Abdel-Salam FS; Mahmoud AA; Basalious EB; Amer MS; Mostafa AA; Elkheshen SA
Int J Pharm; 2019 Nov; 571():118703. PubMed ID: 31536761
[TBL] [Abstract][Full Text] [Related]
57. Effective sustained release of 5-FU-loaded PLGA implant for improving therapeutic index of 5-FU in colon tumor.
Li L; Li C; Zhou J
Int J Pharm; 2018 Oct; 550(1-2):380-387. PubMed ID: 30040972
[TBL] [Abstract][Full Text] [Related]
58. Effect of intraarticular injection of lornoxicam on the articular cartilage & synovium in rat.
Saricaoglu F; Dal D; Atilla P; Iskit AB; Tarhan O; Aşan E; Aypar UA
Indian J Med Res; 2008 Apr; 127(4):362-5. PubMed ID: 18577790
[TBL] [Abstract][Full Text] [Related]
59. Design and in vitro evaluation of novel sustained- release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers.
Hamza Yel-S; Aburahma MH
Pharm Dev Technol; 2010; 15(2):139-53. PubMed ID: 19895367
[TBL] [Abstract][Full Text] [Related]
60. Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System.
Zhu C; Peng T; Huang D; Feng D; Wang X; Pan X; Tan W; Wu C
AAPS PharmSciTech; 2019 Jan; 20(2):64. PubMed ID: 30627822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
